Related content

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

By Vanky E.  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1734-1740

Oxford University Press

Access to resources Recommend Favorite

Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study

By Khattab S.   Mohsen I. A.   Aboul Foutouh I.   Ashmawi H. S.   Mohsen M. N.   van Wely M.   van der Veen F.   Youssef M. Af.  

Gynecological Endocrinology, Vol. 27, Iss. 10, 2011-10 ,pp. : 789-793

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Flutamide–metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

By Ibáñez Lourdes  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1725-1727

Oxford University Press

Access to resources Recommend Favorite

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

By Palomba Stefano   Russo Tiziana   Orio Francesco   Falbo Angela   Manguso Francesco   Cascella Teresa   Tolino Achille   Carmina Enrico   Colao Annamaria   Zullo Fulvio  

Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. : 457-465

Oxford University Press

Access to resources Recommend Favorite